CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,091,356 | -7.1% | 206,767 | +2.8% | 0.00% | +33.3% |
| Q2 2023 | $6,560,175 | -15.1% | 201,109 | -8.4% | 0.00% | -25.0% |
| Q1 2023 | $7,723,360 | -13.1% | 219,476 | +13.1% | 0.00% | -20.0% |
| Q4 2022 | $8,889,080 | +4.4% | 194,000 | +10.4% | 0.01% | 0.0% |
| Q3 2022 | $8,512,000 | +160.2% | 175,689 | +111.0% | 0.01% | +150.0% |
| Q2 2022 | $3,271,000 | +1.5% | 83,262 | -4.9% | 0.00% | 0.0% |
| Q1 2022 | $3,222,000 | -23.4% | 87,509 | -5.2% | 0.00% | 0.0% |
| Q4 2021 | $4,207,000 | -13.2% | 92,289 | -31.9% | 0.00% | 0.0% |
| Q3 2021 | $4,845,000 | +155.0% | 135,589 | +41.1% | 0.00% | +100.0% |
| Q2 2021 | $1,900,000 | +83.8% | 96,063 | +116.0% | 0.00% | 0.0% |
| Q1 2021 | $1,034,000 | +1.6% | 44,478 | -9.2% | 0.00% | 0.0% |
| Q4 2020 | $1,018,000 | -78.9% | 48,995 | -78.0% | 0.00% | -66.7% |
| Q3 2020 | $4,828,000 | +1.8% | 223,024 | +10.8% | 0.00% | -25.0% |
| Q2 2020 | $4,744,000 | +64.6% | 201,261 | -17.7% | 0.00% | +33.3% |
| Q1 2020 | $2,882,000 | +39.6% | 244,410 | +25.5% | 0.00% | +200.0% |
| Q4 2019 | $2,064,000 | +2.0% | 194,674 | +9.4% | 0.00% | 0.0% |
| Q3 2019 | $2,024,000 | -18.4% | 177,980 | -19.3% | 0.00% | 0.0% |
| Q2 2019 | $2,480,000 | +23.2% | 220,610 | -11.4% | 0.00% | 0.0% |
| Q1 2019 | $2,013,000 | +99.3% | 249,070 | +55.7% | 0.00% | 0.0% |
| Q4 2018 | $1,010,000 | -77.8% | 159,980 | -65.4% | 0.00% | 0.0% |
| Q3 2018 | $4,547,000 | -3.0% | 461,782 | -18.2% | 0.00% | 0.0% |
| Q2 2018 | $4,686,000 | +121.5% | 564,718 | +91.9% | 0.00% | 0.0% |
| Q1 2018 | $2,116,000 | +48.0% | 294,309 | +67.4% | 0.00% | 0.0% |
| Q4 2017 | $1,430,000 | +22.5% | 175,832 | +117.9% | 0.00% | 0.0% |
| Q3 2017 | $1,167,000 | -19.2% | 80,703 | -32.6% | 0.00% | 0.0% |
| Q2 2017 | $1,445,000 | +34.2% | 119,745 | +42.6% | 0.00% | 0.0% |
| Q1 2017 | $1,077,000 | -9.1% | 83,994 | -14.0% | 0.00% | 0.0% |
| Q4 2016 | $1,185,000 | -1.0% | 97,705 | -25.1% | 0.00% | 0.0% |
| Q3 2016 | $1,197,000 | +99.8% | 130,514 | +106.1% | 0.00% | – |
| Q2 2016 | $599,000 | -22.4% | 63,313 | -42.4% | 0.00% | -100.0% |
| Q1 2016 | $772,000 | -7.5% | 109,844 | +37.2% | 0.00% | 0.0% |
| Q4 2015 | $835,000 | +48.3% | 80,039 | -5.4% | 0.00% | – |
| Q3 2015 | $563,000 | -15.8% | 84,641 | -15.2% | 0.00% | – |
| Q2 2015 | $669,000 | -21.9% | 99,810 | -21.3% | 0.00% | -100.0% |
| Q1 2015 | $857,000 | -38.4% | 126,794 | -27.1% | 0.00% | 0.0% |
| Q4 2014 | $1,392,000 | -2.5% | 173,821 | -57.2% | 0.00% | 0.0% |
| Q3 2014 | $1,428,000 | +9.3% | 406,271 | +48.4% | 0.00% | 0.0% |
| Q2 2014 | $1,307,000 | -39.9% | 273,814 | +19.6% | 0.00% | -50.0% |
| Q1 2014 | $2,174,000 | -32.6% | 228,934 | -53.9% | 0.00% | 0.0% |
| Q4 2013 | $3,225,000 | +23.0% | 496,358 | +43.1% | 0.00% | 0.0% |
| Q3 2013 | $2,623,000 | – | 346,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |